Art. 5 Regulation (EC) No 1272/2008 of the European Parliament and of the Council of 16 Decembe…

Identification and examination of available information on substances

In forcesince 1 Jul 2026cited 13×
1.

Manufacturers, importers and downstream users of a substance shall identify the relevant available information for the purposes of determining whether the substance entails a physical, health or environmental hazard as set out in Annex I, and, in particular, the following:

(a)

data generated in accordance with any of the methods referred to in Article 8(3);

(b)

epidemiological data and experience on the effects on humans, such as occupational data and data from accident databases;

(c)

any other information generated in accordance with section 1 of Annex XI to Regulation (EC) No 1907/2006;

(ca)

data obtained from new approach methodologies;

(d)

any new scientific information;

(e)

any other information generated under internationally recognised chemical programmes.

The information shall relate to the forms or physical states in which the substance is placed on the market and in which it can reasonably be expected to be used.

2.

Manufacturers, importers and downstream users shall examine the information referred to in paragraph 1 to ascertain whether it is adequate, reliable and scientifically valid for the purpose of the evaluation pursuant to Chapter 2 of this Title.

3.

A substance containing more than one constituent, in the form of an individual constituent, an identified impurity or an additive, for which relevant information referred to in paragraph 1 is available, shall be evaluated using the available information on those known constituents as well as on the substance itself.

4.

For the evaluation of a substance containing more than one constituent pursuant to Chapter 2 in relation to the ‘germ cell mutagenicity’, ‘carcinogenicity’, ‘reproductive toxicity’, ‘endocrine disruption for human health’ and ‘endocrine disruption for the environment’ hazard classes referred to in sections 3.5, 3.6, 3.7, 3.11 and 4.2 of Annex I, the manufacturer, importer and downstream user shall use the relevant available information referred to in paragraph 1 for each of the known constituents.

Relevant available information on a substance containing more than one constituent itself shall be taken into account where one of the following conditions is met:

(a)

the information demonstrates germ cell mutagenic, carcinogenic, or toxic to reproduction properties, or endocrine disruption for human health or the environment;

(b)

the information supports the conclusions based on the relevant available information on the constituents in the substance.

Relevant available information on the substance containing more than one constituent itself demonstrating an absence of the properties referred to in point (a) or less severe properties shall not override the relevant available information on the constituents in the substance.

5.

For the evaluation of a substance containing more than one constituent pursuant to Chapter 2 of this Title in relation to the biodegradation, persistence, mobility and bioaccumulation properties within the ‘hazardous to the aquatic environment’, ‘persistent, bioaccumulative and toxic or very persistent, very bioaccumulative properties’ and ‘persistent, mobile and toxic or very persistent, very mobile properties’ hazard classes referred to in sections 4.1.2.8, 4.1.2.9, 4.3.2.3.1, 4.3.2.3.2, 4.4.2.3.1 and 4.4.2.3.2 of Annex I, the manufacturer, importer and downstream user shall use the relevant available information referred to in paragraph 1 for each of the known constituents in the substance.

Relevant available information on a substance containing more than one constituent itself shall be taken into account where one of the following conditions is met:

(a)

the information demonstrates persistence, mobility and bioaccumulation properties or a lack of degradation.

(b)

the information supports the conclusions based on the relevant available information on the constituents in the substance.

Relevant available information on the substance containing more than one constituent itself demonstrating an absence of the properties referred to in point (a) or less severe properties shall not override the relevant available information on the constituents in the substance.

6.

Paragraphs 4 and 5 shall not apply to substances containing more than one constituent which are extracted from plants or plant parts and which are not chemically modified as defined in Article 3, point (40), of Regulation (EC) No 1907/2006.

7.

For the purpose of paragraph 6, ‘plants’ refers to living or dead organisms from the kingdoms Plantae and Fungi, and includes algae, lichens and yeasts.

8.

For certain substances containing more than one constituent that are not covered by paragraph 6, where the Commission receives evidence that the rules set out in paragraphs 4 or 5 might not be suitable for certain substances containing more than one constituent, the Commission may request the Agency to evaluate the available data.

The Commission is empowered to adopt delegated acts in accordance with Article 53a to amend Annex I by creating a new section and by including and modifying, in that section, the derogations from paragraph 4 or 5 on classification of substances containing more than one constituent. For those delegated acts, the Commission shall take into account scientific evidence, advances in knowledge, and the opinion of the Agency when available, to appropriately classify substances containing more than one constituent provided that a high level of protection of human health and the environment is ensured.

The 10 that are cited most themselves, of 13.

  • Arrêt du Tribunal (deuxième chambre) du 24 octobre 2018. Deza, a.s. contre Commission européenne.Decision

    La requérante fait valoir que le règlement attaqué a été adopté en violation du principe selon lequel seules les substances mises sur le marché de l’Union font l’objet d’une harmonisation de la classification et de …

    24 Oct 2018 · 62017TJ0400

  • Judgment of the General Court (Second Chamber) of 5 July 2023. TIB Chemicals AG v European Commission.Decision

    It should be noted that the applicant has not succeeded in showing that the Commission, in approving the analysis of KEMI and of the RAC, committed a manifest error of assessment and infringed Articles 5, 9, 36 and Article 37(5) of …

    5 Jul 2023 · 62020TJ0639

  • Judgment of the General Court (Ninth Chamber, Extended Composition) of 23 November 2022. CWS Powder Coatings GmbH and Others v European CommDecision

    The Commission disputes those arguments. In the first place, in Joined Cases T‑279/20 and T‑288/20, it submits that it is indeed apparent from the RAC Opinion that the form of titanium dioxide was decisive for classification. However, …

    23 Nov 2022 · 62020TJ0279

  • Regulation (EU) 2024/28652Lawamends

    … Чрез дерогация от член 5, член 6, параграфи 3 и 4, член 9, параграфи 3 и 4, член 10, член 25, параграф 3, член 29, член 31, параграф 1, член 35, член …

  • Judgment of the General Court (Sixth Chamber) of 27 November 2024. Evonik Operations GmbH v European Commission.Decision

    In that regard, Regulation No 1272/2008 provides, in Title V, for a harmonisation procedure throughout the European Union of the classification and labelling of substances, which concerns substances meeting the criteria set out in Annex I …

    27 Nov 2024 · 62022TJ0449

  • Judgment of the General Court (Sixth Chamber) of 27 November 2024. BASF SE and Others v European Commission.Decision

    In that regard, Regulation No 1272/2008 provides, in Title V, for a harmonisation procedure throughout the European Union of the classification and labelling of substances, which concerns substances meeting the criteria set out in Annex I …

    27 Nov 2024 · 62022TJ0453

  • Order of the General Court (Grand Chamber) of 7 September 2010. Etimine SA and AB Etiproducts Oy v European Commission.Decision

    … 1272/2008, in het bijzonder de artikelen 53, lid 1, en 54, lid 3, daarvan, juncto artikel 5 bis, leden 1 tot en met 4, van besluit 1999/468 (zie punten 20-22 hierboven), die gelden voor de vaststelling van de bestreden verordening. Aan …

    7 Sep 2010 · 62008TO0539

  • Order of the General Court (Grand Chamber) of 7 September 2010. Norilsk Nickel Harjavalta Oy and Umicore SA/NV v European Commission.Decision

    … 1272/2008, in het bijzonder de artikelen 53, lid 1, en 54, lid 3, daarvan, juncto artikel 5 bis, leden 1 tot en met 4, van besluit 1999/468 (zie punten 20-22 hierboven), die gelden voor de vaststelling van de bestreden verordening. Aan …

    7 Sep 2010 · 62008TO0532

  • Arrêt de la Cour (septième chambre) du 15 octobre 2020. Deza a.s. contre Commission européenne.Decision

    Aux termes de l’article 5, paragraphe 1, dudit règlement : « Les fabricants, importateurs et utilisateurs en aval d’une substance identifient les informations pertinentes disponibles aux fins de déterminer si cette substance …

    15 Oct 2020 · 62018CJ0813

  • Opinion of Advocate General Ćapeta delivered on 6 February 2025. French Republic v European Commission.Decision

    The RAC formulates its classification proposal by examining the information identified by manufacturers, importers and downstream users on the physical, health or environmental hazard of a given substance for its adequacy, reliability and …

    6 Feb 2025 · 62023CC0071